Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Galinsky IA"'
Autor:
Reiter A; Department of Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany. andreas.reiter@medma.uni-heidelberg.de., Gotlib J; Stanford Cancer Institute/Stanford University School of Medicine, Stanford, CA, USA., Álvarez-Twose I; Institute of Mastocytosis Studies of Castilla La Mancha (CLMast)-Spanish Reference Center (CSUR) for Mastocytosis and CIBERONC, Virgen del Valle Hospital, Toledo, Spain., Radia DH; Guy's and St Thomas' NHS Foundation Trust of Guy's Hospital, London, UK., Lübke J; Department of Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany., Bobbili PJ; Analysis Group, Inc., Boston, MA, USA., Wang A; Analysis Group, Inc., Boston, MA, USA., Norregaard C; Blueprint Medicines Corporation, Cambridge, MA, USA., Dimitrijevic S; Blueprint Medicines Corporation, Zug, Switzerland., Sullivan E; Blueprint Medicines Corporation, Cambridge, MA, USA., Louie-Gao M; Blueprint Medicines Corporation, Cambridge, MA, USA., Schwaab J; Department of Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany., Galinsky IA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Perkins C; Stanford Cancer Institute/Stanford University School of Medicine, Stanford, CA, USA., Sperr WR; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria., Sriskandarajah P; Guy's and St Thomas' NHS Foundation Trust of Guy's Hospital, London, UK., Chin A; Analysis Group, Inc., Boston, MA, USA., Sendhil SR; Analysis Group, Inc., Boston, MA, USA., Duh MS; Analysis Group, Inc., Boston, MA, USA., Valent P; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria., DeAngelo DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Publikováno v:
Leukemia [Leukemia] 2022 Aug; Vol. 36 (8), pp. 2108-2120. Date of Electronic Publication: 2022 Jul 05.
Autor:
Torre M; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Solomon IH; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Sutherland CL; JUNO Therapeutics, Seattle, Washington., Nikiforow S; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., DeAngelo DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Stone RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Vaitkevicius H; Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Galinsky IA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Padera RF; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Trede N; JUNO Therapeutics, Seattle, Washington., Santagata S; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Lab for Systems Pharmacology, Harvard Medical School, Boston, Massachusetts.
Publikováno v:
Journal of neuropathology and experimental neurology [J Neuropathol Exp Neurol] 2018 Oct 01; Vol. 77 (10), pp. 877-882.
Autor:
Welch MA; MD Anderson Cancer Center, Houston, Texas., Ryan JC; Pfizer Inc, New York, New York., Galinsky IA; Dana Farber Cancer Institute, Boston, Massachusetts.
Publikováno v:
Journal of the advanced practitioner in oncology [J Adv Pract Oncol] 2017 Sep-Oct; Vol. 8 (6), pp. 631-636. Date of Electronic Publication: 2017 Sep 01.
Autor:
Etchin J; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Hematology/Oncology, Children's Hospital, Boston, MA, USA., Berezovskaya A; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Conway AS; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Galinsky IA; Department of Medical Oncology, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA, USA., Stone RM; Department of Medical Oncology, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA, USA., Baloglu E; Karyopharm Therapeutics, Newton, MA, USA., Senapedis W; Karyopharm Therapeutics, Newton, MA, USA., Landesman Y; Karyopharm Therapeutics, Newton, MA, USA., Kauffman M; Karyopharm Therapeutics, Newton, MA, USA., Shacham S; Karyopharm Therapeutics, Newton, MA, USA., Wang JC; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Medicine, University of Toronto, Toronto, ON, Canada., Look AT; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Hematology/Oncology, Children's Hospital, Boston, MA, USA.
Publikováno v:
Leukemia [Leukemia] 2017 Jan; Vol. 31 (1), pp. 143-150. Date of Electronic Publication: 2016 May 23.
Autor:
Wu H; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, China.; University of Science and Technology of China, Hefei, China., Wang A; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, China.; University of Science and Technology of China, Hefei, China., Qi Z; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, China.; CHMFL-HCMTC Target Therapy Joint Laboratory, Hefei, China., Li X; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, China.; CHMFL-HCMTC Target Therapy Joint Laboratory, Hefei, China., Chen C; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, China.; CHMFL-HCMTC Target Therapy Joint Laboratory, Hefei, China., Yu K; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, China.; University of Science and Technology of China, Hefei, China., Zou F; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, China.; CHMFL-HCMTC Target Therapy Joint Laboratory, Hefei, China., Hu C; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, China.; University of Science and Technology of China, Hefei, China., Wang W; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, China.; CHMFL-HCMTC Target Therapy Joint Laboratory, Hefei, China., Zhao Z; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, China.; CHMFL-HCMTC Target Therapy Joint Laboratory, Hefei, China., Wu J; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, China.; University of Science and Technology of China, Hefei, China., Liu J; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, China.; University of Science and Technology of China, Hefei, China., Liu X; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, China.; University of Science and Technology of China, Hefei, China., Wang L; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, China.; CHMFL-HCMTC Target Therapy Joint Laboratory, Hefei, China., Wang W; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, China.; CHMFL-HCMTC Target Therapy Joint Laboratory, Hefei, China., Zhang S; CHMFL-HCMTC Target Therapy Joint Laboratory, Hefei, China.; Hefei Cosource Medicine Technology Co. LTD., Hefei, China., Stone RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Galinsky IA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Griffin JD; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Weinstock D; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Christodoulou A; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Wang H; Department of Hematology, The Second Hospital of Anhui Medical University, Hefei, China.; Hematology Research Center, Anhui Medical University, Hefei, China., Shen Y; Department of Hematology, The Second Hospital of Anhui Medical University, Hefei, China.; Hematology Research Center, Anhui Medical University, Hefei, China., Zhai Z; Department of Hematology, The Second Hospital of Anhui Medical University, Hefei, China.; Hematology Research Center, Anhui Medical University, Hefei, China., Weisberg EL; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Liu J; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, China.; CHMFL-HCMTC Target Therapy Joint Laboratory, Hefei, China., Liu Q; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, China.; University of Science and Technology of China, Hefei, China.; CHMFL-HCMTC Target Therapy Joint Laboratory, Hefei, China.; Hefei Science Center, Chinese Academy of Sciences, Hefei, China.
Publikováno v:
Leukemia [Leukemia] 2016 Oct; Vol. 30 (10), pp. 2112-2116. Date of Electronic Publication: 2016 May 25.
Autor:
Liu X; Department of Chemistry, University of Science and Technology of China, Anhui, Hefei, 230036, P. R. China.; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, 230031, Anhui, P. R. China., Wang A; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, 230031, Anhui, P. R. China.; University of Science and Technology of China, Anhui, Hefei, 230036, P. R. China., Liang X; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, 230031, Anhui, P. R. China.; CHMFL-HCMTC Target Therapy Joint Laboratory, Hefei, 230031, Anhui, P. R. China., Liu J; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, 230031, Anhui, P. R. China.; University of Science and Technology of China, Anhui, Hefei, 230036, P. R. China., Zou F; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, 230031, Anhui, P. R. China.; CHMFL-HCMTC Target Therapy Joint Laboratory, Hefei, 230031, Anhui, P. R. China., Chen C; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, 230031, Anhui, P. R. China.; CHMFL-HCMTC Target Therapy Joint Laboratory, Hefei, 230031, Anhui, P. R. China., Zhao Z; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, 230031, Anhui, P. R. China.; CHMFL-HCMTC Target Therapy Joint Laboratory, Hefei, 230031, Anhui, P. R. China., Deng Y; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, 230031, Anhui, P. R. China.; University of Science and Technology of China, Anhui, Hefei, 230036, P. R. China., Wu H; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, 230031, Anhui, P. R. China.; University of Science and Technology of China, Anhui, Hefei, 230036, P. R. China., Qi Z; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, 230031, Anhui, P. R. China.; CHMFL-HCMTC Target Therapy Joint Laboratory, Hefei, 230031, Anhui, P. R. China., Wang B; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, 230031, Anhui, P. R. China.; CHMFL-HCMTC Target Therapy Joint Laboratory, Hefei, 230031, Anhui, P. R. China., Wang L; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, 230031, Anhui, P. R. China.; CHMFL-HCMTC Target Therapy Joint Laboratory, Hefei, 230031, Anhui, P. R. China., Liu F; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, 230031, Anhui, P. R. China.; University of Science and Technology of China, Anhui, Hefei, 230036, P. R. China., Xu Y; Department of Chemistry, University of Science and Technology of China, Anhui, Hefei, 230036, P. R. China., Wang W; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, 230031, Anhui, P. R. China.; CHMFL-HCMTC Target Therapy Joint Laboratory, Hefei, 230031, Anhui, P. R. China., Fernandes SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA., Stone RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA., Galinsky IA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA., Brown JR; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA., Loh T; Department of Chemistry, University of Science and Technology of China, Anhui, Hefei, 230036, P. R. China., Griffin JD; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA., Zhang S; CHMFL-HCMTC Target Therapy Joint Laboratory, Hefei, 230031, Anhui, P. R. China.; Hefei Cosource Medicine Technology Co. Ltd. Hefei, 230031, Anhui, P. R.China., Weisberg EL; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA., Zhang X; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, 230031, Anhui, P. R. China., Liu J; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, 230031, Anhui, P. R. China.; CHMFL-HCMTC Target Therapy Joint Laboratory, Hefei, 230031, Anhui, P. R. China., Liu Q; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, 230031, Anhui, P. R. China.; University of Science and Technology of China, Anhui, Hefei, 230036, P. R. China.; Hefei Science Center, Chinese Academy of Sciences, Hefei, 230031, Anhui, P. R. China.
Publikováno v:
Oncotarget [Oncotarget] 2016 Aug 16; Vol. 7 (33), pp. 53515-53525.
Autor:
Townsend EC, Murakami MA, Christodoulou A, Christie AL, Köster J, DeSouza TA, Morgan EA, Kallgren SP, Liu H, Wu SC, Plana O, Montero J, Stevenson KE, Rao P, Vadhi R, Andreeff M, Armand P, Ballen KK, Barzaghi-Rinaudo P, Cahill S, Clark RA, Cooke VG, Davids MS, DeAngelo DJ, Dorfman DM, Eaton H, Ebert BL, Etchin J, Firestone B, Fisher DC, Freedman AS, Galinsky IA, Gao H, Garcia JS, Garnache-Ottou F, Graubert TA, Gutierrez A, Halilovic E, Harris MH, Herbert ZT, Horwitz SM, Inghirami G, Intlekofer AM, Ito M, Izraeli S, Jacobsen ED, Jacobson CA, Jeay S, Jeremias I, Kelliher MA, Koch R, Konopleva M, Kopp N, Kornblau SM, Kung AL, Kupper TS, LeBoeuf NR, LaCasce AS, Lees E, Li LS, Look AT, Murakami M, Muschen M, Neuberg D, Ng SY, Odejide OO, Orkin SH, Paquette RR, Place AE, Roderick JE, Ryan JA, Sallan SE, Shoji B, Silverman LB, Soiffer RJ, Steensma DP, Stegmaier K, Stone RM, Tamburini J, Thorner AR, van Hummelen P, Wadleigh M, Wiesmann M, Weng AP, Wuerthner JU, Williams DA, Wollison BM, Lane AA, Letai A, Bertagnolli MM, Ritz J, Brown M, Long H, Aster JC, Shipp MA, Griffin JD, Weinstock DM
Publikováno v:
Cancer cell [Cancer Cell] 2016 Jul 11; Vol. 30 (1), pp. 183. Date of Electronic Publication: 2016 Jul 11.
Autor:
Liu X; Department of Chemistry, University of Science and Technology of China, Hefei 230036, Anhui, P. R. China.; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei 230031, Anhui, P. R. China., Wang A; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei 230031, Anhui, P. R. China.; University of Science and Technology of China, Hefei 230036, Anhui, P. R. China., Liang X; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei 230031, Anhui, P. R. China.; CHMFL-HCMTC Target Therapy Joint Laboratory, Hefei 230031, Anhui, P. R. China., Chen C; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei 230031, Anhui, P. R. China.; CHMFL-HCMTC Target Therapy Joint Laboratory, Hefei 230031, Anhui, P. R. China., Liu J; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei 230031, Anhui, P. R. China.; University of Science and Technology of China, Hefei 230036, Anhui, P. R. China., Zhao Z; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei 230031, Anhui, P. R. China.; CHMFL-HCMTC Target Therapy Joint Laboratory, Hefei 230031, Anhui, P. R. China., Wu H; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei 230031, Anhui, P. R. China.; University of Science and Technology of China, Hefei 230036, Anhui, P. R. China., Deng Y; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei 230031, Anhui, P. R. China.; University of Science and Technology of China, Hefei 230036, Anhui, P. R. China., Wang L; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei 230031, Anhui, P. R. China.; CHMFL-HCMTC Target Therapy Joint Laboratory, Hefei 230031, Anhui, P. R. China., Wang B; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei 230031, Anhui, P. R. China.; CHMFL-HCMTC Target Therapy Joint Laboratory, Hefei 230031, Anhui, P. R. China., Wu J; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei 230031, Anhui, P. R. China.; University of Science and Technology of China, Hefei 230036, Anhui, P. R. China., Liu F; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei 230031, Anhui, P. R. China.; University of Science and Technology of China, Hefei 230036, Anhui, P. R. China., Fernandes SM; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA., Adamia S; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA., Stone RM; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA., Galinsky IA; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA., Brown JR; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA., Griffin JD; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA., Zhang S; CHMFL-HCMTC Target Therapy Joint Laboratory, Hefei 230031, Anhui, P. R. China.; Hefei Cosource Medicine Technology Co. LTD., Hefei 230031, Anhui, P.R.China., Loh T; Department of Chemistry, University of Science and Technology of China, Hefei 230036, Anhui, P. R. China., Zhang X; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei 230031, Anhui, P. R. China., Wang W; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei 230031, Anhui, P. R. China.; CHMFL-HCMTC Target Therapy Joint Laboratory, Hefei 230031, Anhui, P. R. China., Weisberg EL; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA., Liu J; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei 230031, Anhui, P. R. China.; CHMFL-HCMTC Target Therapy Joint Laboratory, Hefei 230031, Anhui, P. R. China., Liu Q; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei 230031, Anhui, P. R. China.; CHMFL-HCMTC Target Therapy Joint Laboratory, Hefei 230031, Anhui, P. R. China.; Hefei Science Center, Chinese Academy of Sciences, Hefei 230031, Anhui, P. R. China.
Publikováno v:
Oncotarget [Oncotarget] 2016 May 31; Vol. 7 (22), pp. 32641-51.
Autor:
Townsend EC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA., Murakami MA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA., Christodoulou A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA., Christie AL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA., Köster J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA; Center for Functional Cancer Epigenomics, Dana-Farber Cancer Institute, Boston, MA 02215, USA., DeSouza TA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA., Morgan EA; Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA., Kallgren SP; Department of Biomedical Informatics, Harvard Medical School, Boston, MA 02115, USA., Liu H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA., Wu SC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA., Plana O; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA., Montero J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA., Stevenson KE; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Rao P; Center for Functional Cancer Epigenomics, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Vadhi R; Center for Functional Cancer Epigenomics, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Andreeff M; Leukemia Division, MD Anderson Cancer Center, Houston, TX 77030, USA., Armand P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA., Ballen KK; Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA., Barzaghi-Rinaudo P; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA; Novartis Institutes for Biomedical Research, 4056 Basel, Switzerland., Cahill S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA., Clark RA; Department of Dermatology, Brigham and Women's Hospital, Boston, MA 02115, USA., Cooke VG; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA; Novartis Institutes for Biomedical Research, 4056 Basel, Switzerland., Davids MS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA., DeAngelo DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA., Dorfman DM; Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA., Eaton H; Office of Research and Technology Ventures, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Ebert BL; Department of Hematology, Brigham and Women's Hospital, Boston, MA 02115, USA., Etchin J; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Firestone B; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA; Novartis Institutes for Biomedical Research, 4056 Basel, Switzerland., Fisher DC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA., Freedman AS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA., Galinsky IA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA., Gao H; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA; Novartis Institutes for Biomedical Research, 4056 Basel, Switzerland., Garcia JS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA., Garnache-Ottou F; EFS Bourgogne Franche Comté, INSERM UMR1098, 25020 Besançon, France., Graubert TA; Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA., Gutierrez A; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02215, USA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Halilovic E; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA; Novartis Institutes for Biomedical Research, 4056 Basel, Switzerland., Harris MH; Department of Pathology, Boston Children's Hospital, Boston, MA 02215, USA., Herbert ZT; Molecular Biology Core Facility, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Horwitz SM; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA., Inghirami G; Department of Pathology, Weill Cornell Medical College, New York, NY 10065, USA., Intlekofer AM; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA., Ito M; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA; Novartis Institutes for Biomedical Research, 4056 Basel, Switzerland., Izraeli S; Functional Genomics and Leukemia Research, Sheba Medical Center, Tel Hashomer and Tel Aviv University, Ramat Gan, 52621, Israel., Jacobsen ED; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA., Jacobson CA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA., Jeay S; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA; Novartis Institutes for Biomedical Research, 4056 Basel, Switzerland., Jeremias I; Department of Gene Vectors, Helmholtz Zentrum München, German Research Center for Environmental Health, Marchioninistraße 25, 81377 Munich, Germany; Department of Pediatrics, Dr. von Hauner Children's Hospital, Ludwig Maximilians University, Lindwurmstraße 4, 80337 Munich, Germany., Kelliher MA; Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01655, USA., Koch R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA., Konopleva M; Leukemia Division, MD Anderson Cancer Center, Houston, TX 77030, USA., Kopp N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA., Kornblau SM; Leukemia Division, MD Anderson Cancer Center, Houston, TX 77030, USA., Kung AL; Department of Pediatrics, Columbia University Medical Center, New York, NY 10032, USA., Kupper TS; Department of Dermatology, Brigham and Women's Hospital, Boston, MA 02115, USA., LeBoeuf NR; Department of Dermatology, Brigham and Women's Hospital, Boston, MA 02115, USA., LaCasce AS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA., Lees E; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA; Novartis Institutes for Biomedical Research, 4056 Basel, Switzerland., Li LS; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Look AT; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Murakami M; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA; Novartis Institutes for Biomedical Research, 4056 Basel, Switzerland., Muschen M; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA 94143, USA., Neuberg D; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Ng SY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA., Odejide OO; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA., Orkin SH; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Paquette RR; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Place AE; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Roderick JE; Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01655, USA., Ryan JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA., Sallan SE; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Shoji B; Department of Surgery, Brigham and Women's Hospital, Boston, MA 02115, USA., Silverman LB; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Soiffer RJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA., Steensma DP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA., Stegmaier K; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Stone RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA., Tamburini J; Université Paris Descartes, Faculté de Médecine Sorbonne Paris Cité, 75005 Paris, France., Thorner AR; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, MA 02215, USA., van Hummelen P; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Wadleigh M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA., Wiesmann M; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA; Novartis Institutes for Biomedical Research, 4056 Basel, Switzerland., Weng AP; Department of Pathology, British Columbia Cancer Research Center, Vancouver V5Z 1H8, Canada., Wuerthner JU; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA; Novartis Institutes for Biomedical Research, 4056 Basel, Switzerland., Williams DA; Department of Pediatrics, Columbia University Medical Center, New York, NY 10032, USA., Wollison BM; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Lane AA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA., Letai A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA., Bertagnolli MM; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA 94143, USA., Ritz J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA., Brown M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA; Center for Functional Cancer Epigenomics, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Long H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA; Center for Functional Cancer Epigenomics, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Aster JC; Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA., Shipp MA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA., Griffin JD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA., Weinstock DM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA. Electronic address: dweinstock@partners.org.
Publikováno v:
Cancer cell [Cancer Cell] 2016 Apr 11; Vol. 29 (4), pp. 574-586.
Autor:
Wu H; High Magnetic Field laboratory, Chinese Academy of Sciences, Hefei, Anhui, China.; University of Science and Technology of China, Anhui, Hefei, P. R. China., Hu C; High Magnetic Field laboratory, Chinese Academy of Sciences, Hefei, Anhui, China., Wang A; High Magnetic Field laboratory, Chinese Academy of Sciences, Hefei, Anhui, China.; University of Science and Technology of China, Anhui, Hefei, P. R. China., Weisberg EL; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Chen Y; High Magnetic Field laboratory, Chinese Academy of Sciences, Hefei, Anhui, China., Yun CH; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Wang W; High Magnetic Field laboratory, Chinese Academy of Sciences, Hefei, Anhui, China., Liu Y; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Liu X; High Magnetic Field laboratory, Chinese Academy of Sciences, Hefei, Anhui, China.; University of Science and Technology of China, Anhui, Hefei, P. R. China., Tian B; Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology and Visual Science Key Laboratory, Beijing, China., Wang J; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Zhao Z; High Magnetic Field laboratory, Chinese Academy of Sciences, Hefei, Anhui, China., Liang Y; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Li B; High Magnetic Field laboratory, Chinese Academy of Sciences, Hefei, Anhui, China., Wang L; High Magnetic Field laboratory, Chinese Academy of Sciences, Hefei, Anhui, China., Wang B; High Magnetic Field laboratory, Chinese Academy of Sciences, Hefei, Anhui, China., Chen C; High Magnetic Field laboratory, Chinese Academy of Sciences, Hefei, Anhui, China., Buhrlage SJ; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Qi Z; High Magnetic Field laboratory, Chinese Academy of Sciences, Hefei, Anhui, China., Zou F; High Magnetic Field laboratory, Chinese Academy of Sciences, Hefei, Anhui, China., Nonami A; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Li Y; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Fernandes SM; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Adamia S; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Stone RM; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Galinsky IA; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Wang X; Department of Lymphoma, Sino-US Center for Lymphoma and Leukemia, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China., Yang G; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Griffin JD; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Brown JR; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Eck MJ; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Liu J; High Magnetic Field laboratory, Chinese Academy of Sciences, Hefei, Anhui, China., Gray NS; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Liu Q; High Magnetic Field laboratory, Chinese Academy of Sciences, Hefei, Anhui, China.; University of Science and Technology of China, Anhui, Hefei, P. R. China.; Hefei Science Center, Chinese Academy of Sciences, Hefei, Anhui, China.
Publikováno v:
Leukemia [Leukemia] 2016 Jan; Vol. 30 (1), pp. 173-81. Date of Electronic Publication: 2015 Jul 13.